Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 113

1.

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.

Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White HD, Zeiher AM; ODYSSEY OUTCOMES Committees and Investigators.

N Engl J Med. 2018 Nov 29;379(22):2097-2107. doi: 10.1056/NEJMoa1801174. Epub 2018 Nov 7.

PMID:
30403574
2.

Model of Decision Making Support for a Doctor in the Treatment of an Oncosurgical Patient in a Hospital.

Udalov YD, Vasilyeva IV, Gordienko AV, Bakharev SA.

Stud Health Technol Inform. 2018;255:122-126.

PMID:
30306920
3.

[Changes of Nonspecific Proteinases and Proinflammatory Cytokines in the Clinical Course of Acute Myocardial Infarction of Various Severity].

Soldatova OV, Kubyshkin AV, Gordienko AI, Fomochkina II.

Kardiologiia. 2018 Mar;(3):5-12. Russian.

PMID:
29782265
4.

[Nerve Growth Factor in Patients With Arterial Hypertension: Neuropsychical, Hemodynamic, Metabolic Relationships].

Ushakov AV, Ivanchenko VS, Gordienko AI, Khimich NV, Gagarina AA.

Kardiologiia. 2018 Feb;(2):10-16. Russian.

PMID:
29466195
5.

Development of a Rainbow Lateral Flow Immunoassay for the Simultaneous Detection of Four Mycotoxins.

Foubert A, Beloglazova NV, Gordienko A, Tessier MD, Drijvers E, Hens Z, De Saeger S.

J Agric Food Chem. 2017 Aug 23;65(33):7121-7130. doi: 10.1021/acs.jafc.6b04157. Epub 2016 Dec 12.

PMID:
27936756
6.
7.

Sensitive QD@SiO2-based immunoassay for triplex determination of cereal-borne mycotoxins.

Beloglazova NV, Foubert A, Gordienko A, Tessier MD, Aubert T, Drijvers E, Goryacheva I, Hens Z, De Saeger S.

Talanta. 2016 Nov 1;160:66-71. doi: 10.1016/j.talanta.2016.05.015. Epub 2016 May 3.

PMID:
27591588
8.

Changes of humoral anti-endotoxin immunity and low-intensity inflammation in diabetes mellitus type 1 and 2.

Gordienko AI, Beloglazov VA, Kubyshkin AV.

Patol Fiziol Eksp Ter. 2016 Jul-Sep;60(3):61-7.

PMID:
29244909
9.

Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis.

Sandborn WJ, Feagan BG, Wolf DC, D'Haens G, Vermeire S, Hanauer SB, Ghosh S, Smith H, Cravets M, Frohna PA, Aranda R, Gujrathi S, Olson A; TOUCHSTONE Study Group.

N Engl J Med. 2016 May 5;374(18):1754-62. doi: 10.1056/NEJMoa1513248.

10.

[Features of morbidity community-acquired pneumonia among young recruits].

Serdukov DU, Gordienko AV, Kozlov MS, Mikhailov AA, Davydov PA.

Voen Med Zh. 2015 Oct;336(10):11-4. Russian.

PMID:
26827502
11.

Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial.

Kristensen SL, Preiss D, Jhund PS, Squire I, Cardoso JS, Merkely B, Martinez F, Starling RC, Desai AS, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, McMurray JJ, Packer M; PARADIGM-HF Investigators and Committees.

Circ Heart Fail. 2016 Jan;9(1). pii: e002560. doi: 10.1161/CIRCHEARTFAILURE.115.002560.

13.

[CHARACTERISTIC OF ALTERATIONS OF ARTERIES IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CHRONIC HEPATITIS C].

Guliaev NI, Kuznetsov VV, Poltareĭko DS, Qleksiuk IB, Gordienko AV, Barsukov AV.

Adv Gerontol. 2015;28(1):118-23. Russian.

PMID:
26390622
14.

[Spiritual ties of the Military Medical (Medical and Surgical) Academy].

Gordienko AV, Shamreĭ VK.

Voen Med Zh. 2015 Jan;336(1):67-75. Russian.

PMID:
25916040
15.

Mechanisms of resistance in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.

Perekhrestenko T, Diachenko M, Sviezhentseva I, Gordienko A, Bilko D.

Georgian Med News. 2015 Mar;(240):43-50.

PMID:
25879558
16.

Functional activity of CD34-positive cells in chronic myeloid leukemia patients with different response to imatinib therapy.

Sviezhentseva IO, Perekhrestenko TP, Bilko DI, Gordienko AI, Diachenko MV, Dyagil IS.

Exp Oncol. 2015 Mar;37(1):70-2.

PMID:
25804236
17.

Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.

Packer M, McMurray JJ, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile M, Andersen K, Arango JL, Arnold JM, Bělohlávek J, Böhm M, Boytsov S, Burgess LJ, Cabrera W, Calvo C, Chen CH, Dukat A, Duarte YC, Erglis A, Fu M, Gomez E, Gonzàlez-Medina A, Hagège AA, Huang J, Katova T, Kiatchoosakun S, Kim KS, Kozan Ö, Llamas EB, Martinez F, Merkely B, Mendoza I, Mosterd A, Negrusz-Kawecka M, Peuhkurinen K, Ramires FJ, Refsgaard J, Rosenthal A, Senni M, Sibulo AS Jr, Silva-Cardoso J, Squire IB, Starling RC, Teerlink JR, Vanhaecke J, Vinereanu D, Wong RC; PARADIGM-HF Investigators and Coordinators.

Circulation. 2015 Jan 6;131(1):54-61. doi: 10.1161/CIRCULATIONAHA.114.013748. Epub 2014 Nov 17.

PMID:
25403646
18.

Angiotensin-neprilysin inhibition versus enalapril in heart failure.

McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Investigators and Committees.

N Engl J Med. 2014 Sep 11;371(11):993-1004. doi: 10.1056/NEJMoa1409077. Epub 2014 Aug 30.

19.

[Bacillus subtilis and streptomycin resistant mutant growth in the medium with saponite].

Chebotarev AIu, Gordienko AS, Kurdish IK.

Mikrobiol Z. 2013 Sep-Oct;75(5):62-7. Russian.

PMID:
24479315

Supplemental Content

Loading ...
Support Center